Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA
/in Colorectal Cancer, Dendritic Cells, International Publications /von 1999-07-02 / Int. J. Cancer 1999 Jul;82(1):121-4Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 1999-07-01 / Anticancer Res. 1999 Jul-Aug;19(4C):3403-8A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
/in Breast Cancer, Colorectal Cancer, Dendritic Cells, International Publications, Ovarian Cancer, Pancreatic Cancer /von 1999-06-01 / Clin. Cancer Res. 1999 Jun;5(6):1331-8Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 1999-05-05 / JAMA 1999 May;281(17):1588-9Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells
/in Hyperthermia, International Publications /von 1999-04-01 / J. Immunol. 1999 Apr;162(7):3757-60For the clinical application of thermochemotherapy given at mild temperatures
/in Hyperthermia, International Publications /von 1999-03-01 / Int J Hyperthermia 1999 Mar-Apr;15(2):79-107Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
/in Dendritic Cells, Hypernephroma, International Publications /von 1999-03-01 / J. Urol. 1999 Mar;161(3):777-82Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures
/in International Publications, Newcastle Disease Virus /von 1999-02-01 / Int. J. Oncol. 1999 Feb;14(2):205-15[Hyperthermia in combination with chemotherapy in gynecological cancers]
/in Hyperthermia, International Publications /von 1999-01-09 / Ned Tijdschr Geneeskd 1999 Jan;143(2):85-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Interview mit Prof. Dr. Volker Schirrmacher im Klassik Radio
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum